🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single site, prospective, cross-sectional, controlled clinical st...
Status
Terminated
Location
Tufts Medical Center-New England Eye Center
Start Date
2019-10-03
Trial ID
NCT04125134
Treatments Being Tested
Glaucoma, a leading cause of irreversible blindness worldwide, is character...
Status
Unknown
Location
Centre Hospitalier de l'Université de Montréal
Start Date
2023-03-27
Trial ID
NCT04118920
Treatments Being Tested
This study will evaluate the safety and efficacy of cyclosporine ophthalmic...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00611403
Treatments Being Tested
Subjects with moderate-to-severe Dry Eye by symptoms will be screened inclu...
Status
Completed
Location
Price Vision Group
Start Date
2015-03
Trial ID
NCT02369861
Treatments Being Tested
The efficacy, safety and acceptability of a new artificial tear in subjects...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00514852
Treatments Being Tested
The safety and tolerability of two new artificial tears will be compared to...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00932477
Objective: To evaluate the safety and efficacy of topical cyclosporine eye...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00824811
The purpose of this study is to compare the efficacy and safety of a new ar...
Status
Completed
Location
Milton M. Hom, OD, FAAO
Start Date
2020-06-29
Trial ID
NCT04393441
Treatments Being Tested
The Investigators will compare, in a randomized, prospective, masked and co...
Status
Terminated
Location
University of Colorado Eye Center
Start Date
2007-05
Trial ID
NCT00478036
Treatments Being Tested
Patients are already receiving an intravitreal injection as a standard of c...
Status
Completed
Location
Vistar Eye Center
Start Date
2022-12-22
Trial ID
NCT05542381
Treatments Being Tested